Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan;203(1):29-47.
doi: 10.1007/s10549-023-07107-7. Epub 2023 Sep 20.

Analysing potent biomarkers along phytochemicals for breast cancer therapy: an in silico approach

Affiliations

Analysing potent biomarkers along phytochemicals for breast cancer therapy: an in silico approach

Nivruthi Shekar et al. Breast Cancer Res Treat. 2024 Jan.

Abstract

Purpose: This research focused on the identification of herbal compounds as potential anti-cancer drugs, especially for breast cancer, that involved the recognition of Notch downstream targets NOTCH proteins (1-4) specifically expressed in breast tumours as biomarkers for prognosis, along with P53 tumour antigens, that were used as comparisons to check the sensitivity of the herbal bio-compounds.

Methods: After investigating phytochemical candidates, we employed an approach for computer-aided drug design and analysis to find strong breast cancer inhibitors. The present study utilized in silico analyses and protein docking techniques to characterize and rank selected bio-compounds for their efficiency in oncogenic inhibition for use in precise carcinomic cell growth control.

Results: Several of the identified phytocompounds found in herbs followed Lipinski's Rule of Five and could be further investigated as potential medicinal molecules. Based on the Vina score obtained after the docking process, the active compound Epigallocatechin gallate in green tea with NOTCH (1-4) and P53 proteins showed promising results for future drug repurposing. The stiffness and binding stability of green tea pharmacological complexes were further elucidated by the molecular dynamic simulations carried out for the highest scoring phytochemical ligand complex.

Conclusion: The target-ligand complex of green tea active compound Epigallocatechin gallate with NOTCH (1-4) had the potential to become potent anti-breast cancer therapeutic candidates following further research involving wet-lab experiments.

Keywords: Cancer cells; Docking; Herbal compounds; In silico analysis; Phytochemicals.

PubMed Disclaimer

Conflict of interest statement

The authors have no relevant financial or non-financial interests to disclose.

Figures

Fig. 1
Fig. 1
Graphical representation of the methods employed in this study
Fig. 2
Fig. 2
Types of proteins involved in Target retrieval. Source: Alpha fold Protein structural database
Fig. 3
Fig. 3
Types of herbs and their active bio-compounds 3D conformers retrieved from PubChem database. Source: PubChem database
Fig. 4
Fig. 4
A Binding site residue of P53 protein with phytochemicals, B NOTCH1 Protein, C NOTCH2 protein, and D NOTCH4 protein
Fig. 5
Fig. 5
Docked poses of Green tea ligand Epigallocatechin gallate with P53 and NOTCH 1–4 proteins. Yellow-dotted lines represent Ionic/electrostatic interactions, teal-dotted lines represent strong hydrogen bonds, whilst hydrophobic interactions are represented by grey-dotted lines
Fig. 6
Fig. 6
a Green tea active bio-compound Epigallocatechin gallate during MDS study. b RMSD plot filters based on time frame. c Root mean square deviation (RMSD) plot for ligand structure after three steps (Minimization, equilibration, production)
Fig. 7
Fig. 7
a NOTCH3 protein-Green tea active bio-compound Epigallocatechin gallate before MDS study, b Target-ligand complex during minimization process, c Root mean square deviation (RMSD) plot for target-ligand complex after four steps (Minimization, equilibration, production)

Similar articles

Cited by

References

    1. Burstein HJ, et al. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021. Ann Oncol. 2021;32(10):1216–1235. doi: 10.1016/j.annonc.2021.06.023. - DOI - PMC - PubMed
    1. ‘Breast cancer’. https://www.who.int/news-room/fact-sheets/detail/breast-cancer . Accessed 25 May 2023
    1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA: Cancer J Clin. 2022;72(1):7–33. doi: 10.3322/caac.21708. - DOI - PubMed
    1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA: Cancer J Clin. 2021;71(1):7–33. doi: 10.3322/caac.21654. - DOI - PubMed
    1. ‘Breast cancer|Elsevier Enhanced Reader’. https://reader.elsevier.com/reader/sd/pii/S0140673620323813?token=F04EE0.... Accessed 23 Mar 2023